For: | Zou LQ, Zhang BL, Chang Q, Zhu FP, Li YY, Wei YQ, Guan YS. 3D conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2014; 20(45): 17227-17234 [PMID: 25493039 DOI: 10.3748/wjg.v20.i45.17227] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i45/17227.htm |
Number | Citing Articles |
1 |
Liming Lu, Jingchun Zeng, Zehuai Wen, Chunzhi Tang, Nenggui Xu. Transcatheter arterial chemoembolisation followed by three-dimensional conformal radiotherapy versus transcatheter arterial chemoembolisation alone for primary hepatocellular carcinoma in adults. Cochrane Database of Systematic Reviews 2019; 2019(2) doi: 10.1002/14651858.CD012244.pub2
|
2 |
Houqiao Bai, Peng Gao, Hao Gao, Guangxi Sun, Chonghai Dong, Jian Han, Guosheng Jiang. Improvement of Survival Rate for Patients with Hepatocellular Carcinoma Using Transarterial Chemoembolization in Combination with Three-Dimensional Conformal Radiation Therapy: A Meta-Analysis. Medical Science Monitor 2016; 22: 1773 doi: 10.12659/MSM.895548
|
3 |
Tayab Andrabi, Katy E. French, Muzaffar H. Qazilbash. New Cancer Therapies: Implications for the Perioperative
Period. Current Anesthesiology Reports 2018; 8(4): 362 doi: 10.1007/s40140-018-0303-4
|
4 |
Jun Pang, Guang‐yuan Hao, Yan Chen. Clinical effects and prognosis of stereotactic body radiotherapy combined with transarterial chemoembolization for massive hepatocellular carcinoma. Precision Radiation Oncology 2021; 5(1): 12 doi: 10.1002/pro6.1111
|
5 |
Akram Hamidi, Alexandra Wolf, Rositsa Dueva, Melanie Kaufmann, Kirsten Göpelt, George Iliakis, Eric Metzen. Depletion of HIF-1α by Inducible Cre/loxP Increases the Sensitivity of Cultured Murine Hepatocytes to Ionizing Radiation in Hypoxia. Cells 2022; 11(10): 1671 doi: 10.3390/cells11101671
|
6 |
Ting-Shi Su, Huan-Zhen Lu, Tao Cheng, Ying Zhou, Yong Huang, Ying-Chuan Gao, Min-Yang Tang, Hua-Yan Jiang, Zu-Ping Lian, En-Cun Hou, Ping Liang. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2894-9
|
7 |
Chao Jiang, Xiao-Dong Sun, Wei Qiu, Yu-Guo Chen, Da-Wei Sun, Guo-Yue Lv. Conversion therapy in liver transplantation for hepatocellular carcinoma: What's new in the era of molecular and immune therapy?. Hepatobiliary & Pancreatic Diseases International 2023; 22(1): 7 doi: 10.1016/j.hbpd.2022.10.006
|
8 |
Konstantinos Katsanos, Panagiotis Kitrou, Stavros Spiliopoulos, Ioannis Maroulis, Theodore Petsas, Dimitris Karnabatidis, Sheng-Nan Lu. Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials. PLOS ONE 2017; 12(9): e0184597 doi: 10.1371/journal.pone.0184597
|
9 |
Ryosuke Tateishi, Naoto Fujiwara. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; : 195 doi: 10.1007/978-3-030-21540-8_10
|
10 |
Kayvan Mohkam, Nicolas Golse, Mathieu Bonal, Stanislas Ledochowski, Agnès Rode, Imad E Selmaji, Philippe Merle, Christian Ducerf, Françoise Mornex, Jean-Yves Mabrut. Conformal Radiotherapy as a Bridge to Liver Transplantation for Hepatocellular Carcinoma: Is It Safe?. Future Oncology 2016; 12(13): 1577 doi: 10.2217/fon-2016-0083
|
11 |
Jeong Il Yu, Hee Chul Park. Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis. World Journal of Gastroenterology 2016; 22(30): 6851-6863 doi: 10.3748/wjg.v22.i30.6851
|
12 |
Omar Abdel-Rahman, Zeinab Elsayed. External beam radiotherapy for unresectable hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2017; 2017(3) doi: 10.1002/14651858.CD011314.pub2
|